ArticleScientific reports2026
SNAKE-71: wire-free direct aspiration thrombectomy using the Cereglide 71 catheter for acute large vessel occlusion stroke.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Direct aspiration has become a first-line strategy in mechanical thrombectomy (MT) for large vessel occlusion (LVO) stroke. Advances in large-bore aspiration catheters have enabled wire-free navigation techniques such as SNAKE; however, data on newer 0.071″ platforms remain limited. To evaluate the technical feasibility, angiographic efficacy, and clinical outcomes of the wire-free SNAKE technique using the Cereglide 71 aspiration catheter in acute anterior circulation LVO. Fourteen consecutive patients with acute anterior circulation LVO underwent MT using a direct aspiration-first strategy. The Cereglide 71 catheter was advanced without a microguidewire or microcatheter, following the SNAKE technique. Primary outcomes included successful reperfusion (TICI 2b-3) and first-pass effect (FPE). Secondary outcomes included procedural time, complications, NIHSS improvement, and 90-day modified Rankin Scale (mRS). Successful reperfusion was achieved in all patients (100%). First-pass effect occurred in 57.1% of cases. Mean procedural time was 12.1 ± 5.8 min with a median of one device pass. Median NIHSS improved from 19.5 at admission to 2.0 at 24 h. At 90 days, 78.6% of patients achieved functional independence (mRS 0-2). Distal embolization occurred in 42.9% of cases; however, final reperfusion was maintained in all patients. Wire-free SNAKE thrombectomy using the Cereglide 71 catheter is technically feasible and highly effective, achieving rapid reperfusion and favorable clinical outcomes. This approach represents a viable minimalist aspiration strategy in contemporary MT practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.